ALGIPRO - Alginates by Production Scale Fermentation and Epimerisation
Lead Participant:
CENTRE FOR PROCESS INNOVATION LIMITED
Abstract
The project, ALGIPRO, is an innovative collaborative effort between Norway and the UK. It will translate over 20 years of academic research into an industrial scale production process for alginates. The Centre for Process Innovation Ltd. (UK) is leading the scale-up based on development by SINTEF (Norway). AlgiPharma AS (Norway) will use the product as the Active Pharmaceutical Ingredient in its development of medicines for cystic fibrosis, COPD and chronic wounds. FMC Biopolymer (UK, Norway) will market the product in existing and new applications within the food and pharmaceutical markets.
If successful ALGIPRO will facilitate the introduction of novel medicinal products to the market that will ease patient suffering and potentially reduce healthcare costs. In addition it will be a new tool in fighting multi-drug resistant bacteria.
If successful ALGIPRO will facilitate the introduction of novel medicinal products to the market that will ease patient suffering and potentially reduce healthcare costs. In addition it will be a new tool in fighting multi-drug resistant bacteria.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| CENTRE FOR PROCESS INNOVATION LIMITED | £711,628 | £ 426,976 |
Participant |
||
| INNOVATE UK | £702,051 | £ 1 |
| CPI INNOVATION SERVICES LIMITED | ||
| ALGIPHARMA AS | ||
| FMC BIOPOLYMER UK LIMITED | £2,000 | £ 1,000 |
People |
ORCID iD |
| Matthew Abbott (Project Manager) |